Limosilactobacillus vaginalis

(aka Lactobacillus vaginalis)

Bacteria


General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Limosilactobacillus vaginalis, (aka Lactobacillus vaginalis), is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 13 gut microbiome compilation studies or metastudies. The DNA G+C content is 38-41%. Limosilactobacillus vaginalis is probably a rare gut coloniser. (Hammes2011fBergey; Rossi2016; Walter2008; Embley1989)



  • This organism has been recovered from human faeces, vagina and clinical sources (vaginosis, blood, drainage fluid). The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. It is an opportunistic pathogen. Likely to be transient and not a long-term gut commensal.

  • QUIRKS
  • In 3% of Europeans, so a rare coloniser. Found in human breast milk (Jeurink2013).

  • GENERAL CHARACTERISTICS (Hammes2011fBergey); (Embley1989);
    Character Response
  • ±
  • Strain-dependent hydrolysis or digestion:
  • aesculin;
  • 🌡
  • Temperature tolerance:
  • grows at 30℃; grows at 45℃;
  • H+
  • Acid from carbohydrates usually produced:
  • fructose; galactose; glucose; mannose; ribose; lactose; maltose; melibiose; raffinose; sucrose;
  • Substrates assimilated or utilised:
  • melibiose;
  • Active enzymes:
  • acid phosphatase; arginine dihydrolase; α-galactosidase; β-galactosidase; lipase; lipase C14;

  • SPECIAL FEATURES (Hammes2011fBergey); (Embley1989);
    Character Response
  • Metabolites not produced:
  • H₂S; indole;
  • VP test:
  • not active
  • Nitrate:
  • not reduced

  • RESPONSE TO ANTIBIOTICS (Goldstein2013); (Goldstein2013a);
    Class Active Resistant
  • Penicillins:
  • imipenem; piperacillin-tazobactam;
  • Quinolines:
  • moxifloxacin;
  • Heterocycles:
  • metronidazole;
  • Vancomycins:
  • vancomycin;

  • Dal Bello, F., & Hertel, C. (2006). Oral cavity as natural reservoir for intestinal lactobacilli. Systematic and Applied Microbiology, 29(1), 69–76.


  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Lactobacillales Family:  Lactobacillaceae Genus:  Limosilactobacillus Alt. name:  Lactobacillus vaginalis Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces, vagina and clinical sources (vaginosis, blood, drainage fluid)
    DNA G+C(%):  38-41
    Lower T(℃):  30(+)
    High T(℃):  45(+)
    Aesculin:  d(w) Urea:  neg Gelatin:  neg Casein:  neg Hippurate:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg D-Arabinose:  neg L-Arabinose:  neg Fructose:  + Fucose:  neg D-Fucose:  neg Galactose:  + Glucose:  + Mannose:  + D-Lyxose:  neg Rhamnose:  neg Ribose:  d(+) Sorbose:  neg D-Tagatose:  neg Xylose:  neg L-Xylose:  neg Cellubiose:  neg Gentiobiose:  neg Lactose:  + Maltose:  + Melezitose:  neg Melibiose:  + Sucrose:  + Trehalose:  neg Turanose:  neg Amygdalin:  neg Dextrin:  neg Glycogen:  neg Inulin:  neg Starch:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  neg Inositol:  neg Mannitol:  neg Sorbitol:  neg Xylitol:  neg Arbutin:  neg Gluconate:  neg 2-Ketogluconate:  neg 5-Ketogluconate:  neg Me-α-D-Glc:  neg Me-α-D-Mann:  neg Me-Xyloside:  neg NAc-α-GA:  neg Salicin:  neg

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Melibiose:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  + β-Galactosidase:  + α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg α-Mannosidase:  neg β-Mannosidase:  neg ArgDH:  + γ-Glu transf.:  neg GluDC:  neg OrnDC:  neg AlanineAA:  vr AlaPheProAA:  neg GluGluAA:  neg GlyAA:  vr LeuGlyAA:  vr PyrrolidAA:  neg AlkalineP:  neg AcidP:  + Esterase(C4):  neg EstLip(C8):  neg Lipase:  + Lipase(C14):  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    H2S:  neg Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    piper-taz:  S(MIC50): 1, MIC90: 4, RNG: (0.015–4)
    imipenem:  S(MIC50): 0.5, MIC90: 4, RNG: (0.03–16)
    fidaxomicin:  Var(MIC50): 8, MIC90: >512, RNG: (0.25->512)
    moxifloxacin:  S(MIC50): 0.5, MIC90: 8, RNG: (0.25–16)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    vancomycin:  R(MIC50): 256, MIC90: >512, RNG: (0.5->512)
    metronidazole:  R(MIC50): >32, MIC90: >32, RNG: (2–>32)

    References


    SPECIFIC REFERENCES FOR LIMOSILACTOBACILLUS VAGINALIS
  • Zheng2020 - A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae.
  • Hammes2011fBergey - Bergey's manual of systematic bacteriology. Vol. 3, The Firmicutes. Family Lactobacillaceae, Genus I. Limosilactobacillus
  • Rossi2016 - Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota.
  • Walter2008 - Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research.
  • Nobili2018 - Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
  • Goldstein2013 - In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
  • Goldstein2013a - Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
  • Embley1989 - Lactobacillus vaginalis sp. nov. from the Human Vagina.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR LIMOSILACTOBACILLUS VAGINALIS
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • DalBello2006 - Oral cavity as natural reservoir for intestinal lactobacilli.
  • Dubinkina2017 - Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease
  • Forster2019 - A human gut bacterial genome and culture collection for improved metagenomic analyses.
  • Heilig2002 - Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA.
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • PerezBrocal2015 - Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Wang2020a - Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................
  • GENERAL REFERENCES FOR LIMOSILACTOBACILLUS VAGINALIS
  • Ludwig2009 - Revised road map to the phylum Firmicutes.